两种苯并二氢吡喃-4-酮衍生物的合成

分别以间甲氧基苯酚与间苯二酚为原料,经过3步合成了(E)-7-甲氧基-3(4-甲氧基苯哑甲基)与(E)-7-羟基-3-(3',4',5'-三甲氧基苯哑甲基)取代的苯并二氢吡喃-4-酮.合成路线简单,易于操作,两者的最终收率分别为20.1%和15.3%.     

(E)-2-[2-(6-氯嘧啶-4-基氧基)苯基]-3-甲氧基丙烯酸甲酯的合成工艺改进

以3-(α-甲氧基)亚甲基苯并呋喃-2-(3H)-酮为原料,经3步反应合成了杀菌剂嘧菌酯的重要中间体——(E)-2-[2-(6-氯嘧啶-4-基氧基)苯基]-3-甲氧基丙烯酸甲酯(4),总收率61%。4的结构经NMR表征。     

四(3,4-二甲基苯基)卟啉钴的合成及其光学性质

采用“两步法”,以吡咯和3,4-二甲基苯甲醛为原料,合成了四(3,4-二甲基苯基)卟啉(TDMPP, 1); 1与四水醋酸钴经络合反应合成四(3,4-二甲基苯基)卟啉钴(TDMPPCo, 2),其结构经¹H NMR, IR和荧光光谱确证。考察了金属盐的预处理、反应物浓度、浓缩比和投料比对合成2的收率影响。实验结果表明：在最佳反应条件［γ=n(1)：n(四水乙酸钴)=1 ：7, c（1）为22.95 mmol·L^-1,回流（150 ℃）反应4 h,浓缩比η为75%］下,收率可达82%。     

取代二氢异喹啉基苯基甲基酮的合成新方法

以3,4-二甲氧基苯乙酸为原料,经氯化亚砜酰氯化、3,4-二甲氧基苯乙胺氨解得到了N-(3,4-二甲氧基苯乙基)-2-(3,4-二甲氧基苯基)乙酰胺,经Bischler-Napieraski反应环化同时氧化,合成了Lamellarin重要中间体(6,7-二甲氧基-3,4-二氢异喹啉-1-基)(3,4-二甲氧基苯基)甲基酮,优化了环化的反应条件,其总收率为56%。此方法未见文献报道。产物用1H NMR、13C NMR、MS、IR进行了表征。     

In(OTf)3催化下水相合成2-(3,4,5-三甲氧基苯基)-5-[(5-烷硫基-1,3,4-噁二唑-2-基)硫甲基]-1,3,4-噻二唑类衍生物

以2-巯基-5-(3,4,5-三甲氧基苯基)-1,3,4-噻二唑为原料,经醚化、酰肼化、闭环、硫醚化四步反应合成了10个2-(3,4,5-三甲氧基苯基)-5-[(5-烷硫基-1,3,4-噁二唑-2-基)硫甲基]- 1,3,4-噻二唑类衍生物。通过元素分析、IR、MS、1H NMR和 13C NMR对目标化合物进行了表征。采用In(OTf)3催化下40 oC水相合成目标化合物,具有反应条件温和、合成收率高、催化剂可循环使用等特点。     

(S)-(4-溴-2-甲苯)(3-甲基吗啉)甲酮的合成

以(S)-2-氨基丙醇和氯乙酰氯为起始原料,经酰化和环合反应制得(S)-5-甲基吗啉-3-酮（4）; 4经还原制得(S)-3-甲基吗啉(5); 5与4-溴-2-甲基苯甲酸酰化缩合合成了(S)-(4-溴2-甲基苯基)(3-甲基吗啉)-甲酮,总收率57%,其结构经¹H NMR 和 ¹³C NMR确证。     

HIV-1 RT抑制剂研究I.1,3-二苄基-6-(3,4-环氧丁基)尿嘧啶的合成

报道了1,3-二苄基-6-(3,4-环氧丁基)尿嘧啶的合成新方法.以6-甲基尿嘧啶(1)为起始物,经1,3-二苄基-6-甲基尿嘧啶(2)及未见文献报道的1,3-二苄基-6-(3-丁烯基)尿嘧啶(3)和1,3-二苄基-6-(3-羟基-4-溴丁基)尿嘧啶(4),首次高收率合成了1,3-二苄基-6-(3,4-环氧丁基)尿嘧啶(5),并对其化学结构进行了表征.     

2-甲基-6-(3-甲基-2-丁烯基)对苯二醌的合成

以邻甲基苯酚为原料,与1-氯-2-甲基-2-丁烯反应生成2-甲基-6-(3-甲基-2-丁烯基)苯酚,然后催化氧化得到目标产物2-甲基-6-(3-甲基-2-丁烯基)对苯二醌。该合成路线简单,易于操作,最终收率51%。     

(2R,4S)-4-甲基-2-哌啶甲酸乙酯的合成

以S-(-)-α-苯乙胺为原料,经一锅法制得1-(1-苄基)-6-乙氧羰基-4-甲基-3,4-二氢哌啶(3),收率58.7%。以10%Pd/C为催化剂,3经催化氢化脱苄合成了4-甲基-2-哌啶甲酸乙酯(4),收率96%;4通过减压分馏得(2R,4S)-4,含量95%,其结构经1H NMR,IR和MS确证。     

1-(3,5-二甲基苯基)-1-[(1S,4S)-1,7,7-三甲基双环[2.2.1]庚烷-2-基]肼的合成工艺改进

以3,5-二甲基苯胺和2-莰酮为起始原料,在微波促进下,经缩合反应制得N-(3,5-二甲基苯基)-1-(1S,4S)-1,7,7-三甲基二环[2.2.1]庚烷-2-亚胺(1);1经硼氢化钠还原后再与羟胺-O-磺酸经胺化反应合成了1-(3,5-二甲基苯基)-1-[(1S,4S)-1,7,7-三甲基双环[2.2.1]庚烷-2-基]肼,总收率70.4%,其结构经1H NMR和ESI-MS确证。     

(S)-(-)-5-对苄氧基苄基-2,4-噁唑烷二酮的合成

L-酪氨酸经O-苄基化和重氮化反应得到关键中间体--手性3-(对苄氧基苯基)-α-羟基丙酸(4); 4经酯化、氨化和环化反应合成了(S)-(-)-5-对苄氧基苄基-2,4-噁唑烷二酮,总收率10%, 95.4%e.e.,其结构经1H NMR和HR-MS表征.     

Preparation,molecular structures,and characteristic properties of (E)-1-(2-furyl)- and (E)-1-(2-thienyl)-2-(3-guaiazulenyl)ethylenes and (E)-1-(3-furyl)- and (E)-1-(3-thienyl)-2-(3-guaiazulenyl)ethylenes

Wittig reactions of 2-furaldehyde (20) [and thiophene-2-carbaldehyde (21)] with (3-guaiazulenylmethyl)triphenylphosphonium bromide (19) in ethanol containing NaOEt at 25 °C for 24 h under argon give (E)-1-(2-furyl)-2-(3-guaiazulenyl)ethylene (22E) and (E)-1-(2-thienyl)-2-(3-guaiazulenyl)ethylene (23E) in 53 and 36% yields. Similarly, Wittig reactions of 3-furaldehyde (29) [and thiophene-3-carbaldehyde (30)] with 19 under the same reaction conditions as for 20 and 21 afford (E)-1-(3-furyl)-2-(3-guaiazulenyl)ethylene (31E) and (E)-1-(3-thienyl)-2-(3-guaiazulenyl)ethylene (32E) in 32 and 46% yields. Molecular structures and characteristic properties as well as preparation of the title E (i.e., one of the geometrical isomers) forms, with a view to comparative study, are reported. Moreover, reactions of those conjugated π-electron systems with TCNE (=tetracyanoethylene) in benzene [and in DMF (=N,N-dimethylformamide)] at 25 °C for 24 h under argon yield unique products, possessing interesting molecular structures, respectively, whose characteristic properties and crystal structures are documented, also.     

(S)-(-)-norlaudanosine和(S)-(-)-O,O-dimethylcoclaurine的合成

以高藜芦胺为起始原料,经N-磺酰化反应制得高藜芦磺酰胺(2);2分别与芳乙烯甲醚经对甲苯磺酸催化的Pictet-Spengler反应后用金属钠脱除Ts基团合成了(±)-norlaudanosine(5a)和(±)-O,O-dimethylcoclaurine(5b);使用半量拆分法,以N-乙酰-L-苯丙氨酸为拆分剂,制得(S)-(-)-5a和(S)-(-)-5b,其结构经1H NMR,13C NMR,IR,MS和HR-ESI-MS确证。     

Synthesis and Crystal Structure of 1-（Trifluoromethyl）-1-（propioloyl）-（E）-3-oxo-（2-thienyl）-（2-naphthylamine）

1INTRODUCTIONTheSchiffbasesderivedfromb-diketonesandaliphaticamineshavebeenshowntoexistastheketo-amines.However,ifsubstituentseitherattheketooraminogrouparearomatic,itmaybeexpectedtheenoliminewillbethefavoredtautomericform[1].Recently,someSchiffbasesderivedfromTTA(4,4,4-trifluoro-1-(2-thienyl)-1,3-butanedione)andPMBPhavebeenstudiedbyWang[2]andYu[3]etal.Inordertostudytherelationshipbetweenthestructuresandperformancesofthesecompounds,thetitlecom-poundwillbereportedherein.2EXPERIMENT…     

An Efficient Synthesis of Optically Pure (R)- and (S)-2-(aminomethyl)alanine ((R)- and (S)-ama) and (R)- and (S)-2-(aminomethyl)leucine ((R)- and (S)-aml)

An efficient synthesis of enantiomerically pure (R)- and (S)-2-(aminomethyl)alanine ((R)- and (S)-Ama) 1a and (R)- and (S)-2-(aminomethyl)leucine ((R)- and (S)-Aml) 1b is described (Schemes 1 and 2). Resolution of the racemic amino acids was achieved using L -phenylalanine cyclohexylamide ( 2 ) as chiral auxiliary. The free amino acids 1a, b were converted to the N^α-Boc,N^γ-Z-protected derivatives 11a, b (Scheme 3) ready for incorporation into peptides. Based on the three crystal structures of the diastereoisomeric peptides 8a, 8b , and 9b , the absolute configurations in both series were determined. β-Turn type-I geometries were observed for structures 8b and 9b , whereas 8a crystallized in an extended backbone conformation.     

Smectic A and smectic C materials: partially deuteriated chiral liquid crystals (S)-(-)-2-methylbuty 4-(4-(d13)-hexyloxyphenyl)benzoate and (S)-(-)-2-methylbutyl 4-(4-(d17)-octyloxyphenyl)benzoate

In order to study the difference in microscopic orientation of ferro- and antiferroelectric liquid crystalline molecules, we synthesized the partially deuteriated chiral compounds, (S)-(^-)-2-methylbutyl 4-(4-(d₁₃)-hexyloxy- and (S)-(^-)-2-methylbutyl 4-(4-(d₁₇)-octyloxy-phenyl)benzoates. Fundamental physical properties such as phase transition temperatures, spontaneous polarization and tilt angle were determined. Polarized FTIR measurements were also made to provide information on molecular structure and orientation.     

Synthesis of (S)-5-(1-aminoethyl)-2-(cyclohexylmethoxy)benzamide

Three short syntheses of the title compound, a peptidomimetic for the Glu-Glu-Ile-NH₂ portion of Ac-pTyr-Glu-Glu-Ile-NH₂, a high affinity peptide for the Src SH2 domain, are described. The most efficient route produces the title compound in a final enantiopurity of 94% ee.